Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Nevro Corp. currently manages 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. This portfolio is concentrated in 1 distinct art unit, indicating a focused prosecution strategy despite the involvement of 3 distinct examiners. The distribution of work across these examiners suggests that each individual is handling a single pending action.
ROANE, AARON F is identified as the busiest examiner for this portfolio, currently overseeing 1 busiest examiner pending action. Because the total number of pending office actions is 3, the workload is distributed among the assigned staff. This lack of examiner concentration within the single art unit may lead to varied prosecution outcomes depending on individual examiner tendencies.
Practitioners should note that while the technology area is broad, the focus on 1 distinct art unit simplifies the procedural landscape. The presence of 3 distinct examiners for the pending office actions means that no single examiner holds a majority of the active cases. This diversification requires tailored approaches for each pending matter rather than a unified strategy for a single primary examiner.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| §102 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROANE, AARON F | 1 | 73.4% | +9.7% |
| ALTER MORSCHAUSER, ALYSSA MARGO | 1 | 76.5% | +15.8% |
| BAIG, RUMAISA RASHID | 1 | 34.0% | +33.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18352846 | SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION | ALTER MORSCHAUSER, ALYSSA MARGO | 184d overdue |
| 17991810 | THERAPEUTIC MODULATION TO TREAT BLOOD GLUCOSE ABNORMALITIES, INCLUDING TYPE 2 DIABETES, AND/OR REDUCE HBA1C LEVELS, AND ASSOCIATED SYSTEMS AND METHODS | BAIG, RUMAISA RASHID | 19d overdue |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18916512 | SYSTEMS AND METHODS FOR CONCURRENTLY DELIVERING HIGH FREQUENCY AND LONG PULSE WIDTH ELECTRICAL STIMULATION | ROANE, AARON F | — | §102 | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18352846 | SYSTEMS AND METHODS FOR DELIVERING NEUROSTIMULATION, INCLUDING REDUCED DOSES OF NEUROSTIMULATION | ALTER MORSCHAUSER, ALYSSA MARGO | 3796 | §103 | Final Rejection | 184d overdue | Pending | Jul 14, 2023 |
| 17991810 | THERAPEUTIC MODULATION TO TREAT BLOOD GLUCOSE ABNORMALITIES, INCLUDING TYPE 2 DIABETES, AND/OR REDUCE HBA1C LEVELS, AND ASSOCIATED SYSTEMS AND METHODS | BAIG, RUMAISA RASHID | 3796 | §103 | Final Rejection | 19d overdue | Pending | Nov 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial